Most popular articles on behalf of touchONCOLOGY
We are pleased to present this selection of peer reviewed, open access articles published in the latest editions of European Oncology & Haematology and Oncology & Hematology Review (US). Please also enjoy a selection of touchONCOLOGY videos, filmed at this years ECC congress in Vienna, highlighting some of the key topics from the meeting.
touchONCOLOGY aims to provide concise and insight content on the latest research and industry developments from leading experts in the field.
Register here to receive the FREE Monthly Scientific eNewsletter which provides a snapshot of our latest cutting-edge and future member only content.
Many thanks and enjoy!
Nicola Cartridge, Managing Editor
Contribution of the Prosigna® (PAM50) Gene Signature Assay as a New-generation Genomic Test for Treatment Decision-making in Early Breast Cancer
Nadia Harbeck, Rachel Wuerstlein, Karl Sotlar
European Oncology & Haematology, 2015;11(2):85–91
Trends in the Cost-effectiveness of Chemoprevention for Breast Cancer—2001 to 2015
Austin M Coe, Katherine D Crew
Oncology & Hematology Review, 2015;11(2):104–9
How Do We Move Forward with Vaccines in Lung Cancer?
Anouck Ottevaere, Nele De Brucker, Johan Vansteenkiste
European Oncology & Haematology, 2015;11(2):92–3
Adverse Event Management in Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Christian Rolfo, Ignacio Gil-Bazo, Solange Peters
European Oncology & Haematology, 2015;11(2):94–9
Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids
Nicola Fazio, Anna Maria Frezza
European Oncology & Haematology, 2015;11(2):100–4
Making Sense of the Advances in the Treatment of Hepatocellular Carcinoma
Imane El-Dika, Ghassan K Abou-Alfa
Oncology & Hematology Review, 2015;11(2):141–2
Managing Immunotherapy-related Side Effects
Claire Friedman, Michael Postow
Oncology & Hematology Review, 2015;11(2):143–4
Individualized Treatment of Diffuse Large B-cell Lymphoma— The Evolving Role of Molecular-subtype-specific Therapy
Gita Thanarajasingam, Nabila Bennani-Baiti, Grzegorz S Nowakowski
Oncology & Hematology Review, 2015;11(2):113–4
Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma
Paul G Richardson, Antonio Palumbo, Stephen A Schey, Meletios A Dimopoulos, Thierry Facon, Katja C Weisel, Peter O’Gorman, Xavier Leleu,Martha Q Lacy, Matthew J Streetly, Joseph R Mikhael, David S Siegel , Jesus F San Miguel, Kenneth C Anderson
European Oncology & Haematology, 2015;11(2):109–17
Monoclonal Antibodies for the Treatment of Multiple Myeloma— A New Paradigm
Nidhi Tandon, Shaji K Kumar
Oncology & Hematology Review, 2015;11(2):115–21
Axel Merseburger - Relapse after ADT in Patients with Prostate Cancer
Axel Merseburger - Filmed at the ECC 2015, Vienna Part 1/3: Axel Merseburger discusses approaches to prevent relapse after ADT in patients with prostate cancer.
Federico Cappuzzo - New Research in the Treatment of NSCLC
Federico Cappuzzo - Filmed at the ECC 2015, Vienna Part 2/3: Federico Cappuzzo reviews the latest research and developments in the treatment of NSCLC.
Paulo Ascierto - Pathway Immune Checkpoint Inhibitors
Paulo Ascierto - Filmed at the ECC 2015, Vienna Part 3/3: Paulo Ascierto discusses the the next steps for PD-1 pathway immune checkpoint inhibitors.
Bernardo Rapoport - Unmet Needs in Supportive Cancer Care
Bernardo Rapoport - Filmed at the ECC 2015, Vienna Part 4/4: Bernardo Rapoport highlights the new key data on agents targeting molecular signalling pathways associated with chemotherapy-induced nausea and vomiting.
Karim Fizazi - Impact of Recent Research on Clinical Outcomes
Karim Fizazi - Filmed at the ECC 2015, Vienna Part 2/2: Karim Fizazi discusses the impact of recent research into prognostic and predictive tests in prostate cancer on the clinical outcomes.